Please assess the completion status of the following clinical trial:

Trial Title: Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18-60 year-old~* American Society of Anesthesiology(ASA) status I\~II~* Elective craniotomy patients with supratentorial eloquent glioma diagnosed by MRI (In control group: volunteers without neuro-diseases)~Exclusion Criteria:~* Unable to comprehend and cooperate with the neurologic examination~* Impaired mental status~* Taking sedative drugs in the past 24 hours~* Taking pain reliever in the past 24 hours~* Drug and/or alcohol abuse~* Pregnant and/o lactating women~* Recurrent brain tumors~* Multiple brain tumors~* Accepting radiotherapy or chemotherapy~* Complicated with intracranial trauma and vascular diseases~* Complicated with grand mal epilepsy ( in midazolam group)~* Complicated with neuromuscular diseases~* Complicated with cutaneous paresthesia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Glioma group (Type: EXPERIMENTAL): Patients in this group will be administered sedatives (midazolam or propofol or dexmedetomidine) titrating to mild sedation.
- non-neurosurgical group (Type: ACTIVE_COMPARATOR): patients in this group will be administered the same sedative midazolam as compared glioma group, and titrate to mild sedation.

Based on this trial design, predict the completion outcome and termination type (if applicable).